Stock Price
50.19
Daily Change
0.26 0.52%
Monthly
22.27%
Yearly
-29.56%
Q2 Forecast
47.39

EPS Reference Time Actual Consensus Previous
2026-04-27 FY2026Q1 PM 2.10 0.09 -0.07
2026-01-26 FY2025Q4 PM -6.35 0.27 -0.38
2026-01-25 FY2025Q4 PM 0.27 -0.38
2025-10-27 FY2025Q3 PM -1.38 0.54 0.96
2025-07-21 FY2025Q2 PM -0.64 0.61 0.25



Peers Price Chg Day Year Date
Alnylam Pharmaceuticals 302.39 6.76 2.29% 3.24% May/28
Amgen 336.02 -0.04 -0.01% 18.51% May/28
American Homes 4 Rent 24.21 -0.25 -1.02% -35.01% May/27
Alexandria Real Estate Equities 50.19 0.26 0.52% -29.56% May/28
AvalonBay Communities 184.91 -1.32 -0.71% -10.25% May/28
Brandywine Realty 3.03 0.02 0.66% -27.86% May/27
Bristol-Myers Squibb 56.83 -0.69 -1.20% 18.77% May/28
Boston Properties 60.79 0.07 0.12% -11.71% May/28
Veris Residential 18.99 -0.01 -0.05% 26.85% May/26
Camden Property 108.27 0.18 0.17% -7.39% May/28

Indexes Price Day Year Date
US400 3723 7.47 0.20% 23.58% May/28
US500 7565 44.97 0.60% 27.96% May/28

Alexandria Real Estate Equities traded at $50.50 this Thursday May 28th, increasing $0.57 or 1.14 percent since the previous trading session. Looking back, over the last four weeks, Alexandria Real Estate Equities gained 23.02 percent. Over the last 12 months, its price fell by 29.12 percent. Looking ahead, we forecast Alexandria Real Estate Equities to be priced at 47.39 by the end of this quarter and at 44.56 in one year, according to Trading Economics global macro models projections and analysts expectations.

Alexandria Real Estate Equities, Inc. is a real estate investment (REIT). The Company is engaged in the business of providing space for lease to the life science and technology industries. It focuses on collaborative life science and technology campuses. It develops urban cluster campuses and ecosystems. Its properties are located in various areas, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland and Research Triangle Park. Its properties include Alexandria Center for Life Science South San Francisco; Alexandria Center for Life Science San Carlos, and Alexandria Center for Life Science Long Island City. Its asset base consisted of approximately 36.7 million and rentable square feet of operating properties and 3.4 million rentable square feet of Class A properties undergoing construction, 7.7 million rentable square feet of near-term and intermediate-term development and redevelopment projects, and 10.3 million feet of future development projects